BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $254,000 | -20.9% | 5,023 | 0.0% | 0.02% | +6.2% |
| Q1 2022 | $321,000 | -18.9% | 5,023 | +35.8% | 0.02% | -30.4% |
| Q4 2021 | $396,000 | +0.3% | 3,700 | -3.7% | 0.02% | 0.0% |
| Q3 2021 | $395,000 | +16.9% | 3,842 | 0.0% | 0.02% | +9.5% |
| Q2 2021 | $338,000 | +3.7% | 3,842 | +14.4% | 0.02% | -8.7% |
| Q1 2021 | $326,000 | +43.6% | 3,357 | +65.6% | 0.02% | +21.1% |
| Q4 2020 | $227,000 | +7.6% | 2,027 | -10.8% | 0.02% | -20.8% |
| Q3 2020 | $211,000 | -72.3% | 2,272 | -76.1% | 0.02% | -61.9% |
| Q4 2019 | $763,000 | +43.4% | 9,526 | +31.6% | 0.06% | +34.0% |
| Q3 2019 | $532,000 | +6.0% | 7,238 | +36.0% | 0.05% | 0.0% |
| Q2 2019 | $502,000 | +60.4% | 5,323 | +35.9% | 0.05% | +62.1% |
| Q1 2019 | $313,000 | -51.2% | 3,916 | -67.1% | 0.03% | -52.5% |
| Q4 2018 | $642,000 | -0.9% | 11,914 | +43.5% | 0.06% | +15.1% |
| Q3 2018 | $648,000 | +213.0% | 8,300 | +268.4% | 0.05% | +178.9% |
| Q1 2018 | $207,000 | – | 2,253 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |